Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone

A comparison of fetal neurobehaviors and infant outcomes

Lauren M Jansson, Janet Ann DiPietro, A. Elko, E. L. Williams, Lorraine A Milio, M. Velez

Research output: Contribution to journalArticle

Abstract

Background: It is suspected that there is a continuum of impairment among prenatally drug-exposed infants, such that opioid and/or poly-drug exposure confers the highest risk for adverse neonatal outcomes than other classes of substances or single substance exposures. Suitable control groups are difficult to identify. This study compared fetal neurobehavioral development and infant outcomes in offspring of three groups of pregnant women in drug treatment. Exposure groups include: Methadone. +. other illicit substances (MM. +. Poly) and two groups currently abstinent for poly drug exposures: Methadone only (MM/A) and Non-Methadone (NM/A). Methods: Forty-nine women (19 MM. +. Poly, 18 MM/A, and 12 NM/A) underwent fetal monitoring at 36 weeks gestation at peak and trough levels of methadone (MM. +. Poly; MM/A) or at comparable morning and afternoon times (NM/A). Fetal heart rate (FHR), heart rate variability (FHRV) and motor activity (FM) data were collected. Infant measures included birth outcomes and Neonatal Abstinence Syndrome (NAS) assessment. Results: As compared to the NM/A group, cardiac measures were decreased in methadone-exposed fetuses at peak levels. FHR was significantly more suppressed in the MM. +. Poly group. FM was significantly lower in the MM/A vs. the NM/A group at both peak and trough, indicative of more persistent exposure effects. The MM. +. Poly group delivered 1 week earlier and required NAS pharmacological treatment twice as often as the MM/A group. Conclusions: Results support the notion that poly-drug exposure may potentiate the effects of methadone on the fetus and infant and highlights the need for intensified treatment for methadone-maintained women who abuse other substances.

Original languageEnglish (US)
Pages (from-to)213-219
Number of pages7
JournalDrug and Alcohol Dependence
Volume122
Issue number3
DOIs
StatePublished - May 1 2012

Fingerprint

Methadone
Pregnancy
Neonatal Abstinence Syndrome
Pharmaceutical Preparations
Fetal Heart Rate
Fetal monitoring
Fetus
Fetal Monitoring
Drug therapy
Fetal Development
Opioid Analgesics
Substance-Related Disorders
Pregnant Women
Motor Activity
Therapeutics
Heart Rate
Parturition
Pharmacology
Control Groups

Keywords

  • Fetal neurobehavior
  • Methadone
  • Neonatal abstinence syndrome
  • Poly-drug exposure

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Toxicology
  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{85ed208c2d3d49728afc77c7e75451bf,
title = "Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: A comparison of fetal neurobehaviors and infant outcomes",
abstract = "Background: It is suspected that there is a continuum of impairment among prenatally drug-exposed infants, such that opioid and/or poly-drug exposure confers the highest risk for adverse neonatal outcomes than other classes of substances or single substance exposures. Suitable control groups are difficult to identify. This study compared fetal neurobehavioral development and infant outcomes in offspring of three groups of pregnant women in drug treatment. Exposure groups include: Methadone. +. other illicit substances (MM. +. Poly) and two groups currently abstinent for poly drug exposures: Methadone only (MM/A) and Non-Methadone (NM/A). Methods: Forty-nine women (19 MM. +. Poly, 18 MM/A, and 12 NM/A) underwent fetal monitoring at 36 weeks gestation at peak and trough levels of methadone (MM. +. Poly; MM/A) or at comparable morning and afternoon times (NM/A). Fetal heart rate (FHR), heart rate variability (FHRV) and motor activity (FM) data were collected. Infant measures included birth outcomes and Neonatal Abstinence Syndrome (NAS) assessment. Results: As compared to the NM/A group, cardiac measures were decreased in methadone-exposed fetuses at peak levels. FHR was significantly more suppressed in the MM. +. Poly group. FM was significantly lower in the MM/A vs. the NM/A group at both peak and trough, indicative of more persistent exposure effects. The MM. +. Poly group delivered 1 week earlier and required NAS pharmacological treatment twice as often as the MM/A group. Conclusions: Results support the notion that poly-drug exposure may potentiate the effects of methadone on the fetus and infant and highlights the need for intensified treatment for methadone-maintained women who abuse other substances.",
keywords = "Fetal neurobehavior, Methadone, Neonatal abstinence syndrome, Poly-drug exposure",
author = "Jansson, {Lauren M} and DiPietro, {Janet Ann} and A. Elko and Williams, {E. L.} and Milio, {Lorraine A} and M. Velez",
year = "2012",
month = "5",
day = "1",
doi = "10.1016/j.drugalcdep.2011.10.003",
language = "English (US)",
volume = "122",
pages = "213--219",
journal = "Drug and Alcohol Dependence",
issn = "0376-8716",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone

T2 - A comparison of fetal neurobehaviors and infant outcomes

AU - Jansson, Lauren M

AU - DiPietro, Janet Ann

AU - Elko, A.

AU - Williams, E. L.

AU - Milio, Lorraine A

AU - Velez, M.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Background: It is suspected that there is a continuum of impairment among prenatally drug-exposed infants, such that opioid and/or poly-drug exposure confers the highest risk for adverse neonatal outcomes than other classes of substances or single substance exposures. Suitable control groups are difficult to identify. This study compared fetal neurobehavioral development and infant outcomes in offspring of three groups of pregnant women in drug treatment. Exposure groups include: Methadone. +. other illicit substances (MM. +. Poly) and two groups currently abstinent for poly drug exposures: Methadone only (MM/A) and Non-Methadone (NM/A). Methods: Forty-nine women (19 MM. +. Poly, 18 MM/A, and 12 NM/A) underwent fetal monitoring at 36 weeks gestation at peak and trough levels of methadone (MM. +. Poly; MM/A) or at comparable morning and afternoon times (NM/A). Fetal heart rate (FHR), heart rate variability (FHRV) and motor activity (FM) data were collected. Infant measures included birth outcomes and Neonatal Abstinence Syndrome (NAS) assessment. Results: As compared to the NM/A group, cardiac measures were decreased in methadone-exposed fetuses at peak levels. FHR was significantly more suppressed in the MM. +. Poly group. FM was significantly lower in the MM/A vs. the NM/A group at both peak and trough, indicative of more persistent exposure effects. The MM. +. Poly group delivered 1 week earlier and required NAS pharmacological treatment twice as often as the MM/A group. Conclusions: Results support the notion that poly-drug exposure may potentiate the effects of methadone on the fetus and infant and highlights the need for intensified treatment for methadone-maintained women who abuse other substances.

AB - Background: It is suspected that there is a continuum of impairment among prenatally drug-exposed infants, such that opioid and/or poly-drug exposure confers the highest risk for adverse neonatal outcomes than other classes of substances or single substance exposures. Suitable control groups are difficult to identify. This study compared fetal neurobehavioral development and infant outcomes in offspring of three groups of pregnant women in drug treatment. Exposure groups include: Methadone. +. other illicit substances (MM. +. Poly) and two groups currently abstinent for poly drug exposures: Methadone only (MM/A) and Non-Methadone (NM/A). Methods: Forty-nine women (19 MM. +. Poly, 18 MM/A, and 12 NM/A) underwent fetal monitoring at 36 weeks gestation at peak and trough levels of methadone (MM. +. Poly; MM/A) or at comparable morning and afternoon times (NM/A). Fetal heart rate (FHR), heart rate variability (FHRV) and motor activity (FM) data were collected. Infant measures included birth outcomes and Neonatal Abstinence Syndrome (NAS) assessment. Results: As compared to the NM/A group, cardiac measures were decreased in methadone-exposed fetuses at peak levels. FHR was significantly more suppressed in the MM. +. Poly group. FM was significantly lower in the MM/A vs. the NM/A group at both peak and trough, indicative of more persistent exposure effects. The MM. +. Poly group delivered 1 week earlier and required NAS pharmacological treatment twice as often as the MM/A group. Conclusions: Results support the notion that poly-drug exposure may potentiate the effects of methadone on the fetus and infant and highlights the need for intensified treatment for methadone-maintained women who abuse other substances.

KW - Fetal neurobehavior

KW - Methadone

KW - Neonatal abstinence syndrome

KW - Poly-drug exposure

UR - http://www.scopus.com/inward/record.url?scp=84859650788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859650788&partnerID=8YFLogxK

U2 - 10.1016/j.drugalcdep.2011.10.003

DO - 10.1016/j.drugalcdep.2011.10.003

M3 - Article

VL - 122

SP - 213

EP - 219

JO - Drug and Alcohol Dependence

JF - Drug and Alcohol Dependence

SN - 0376-8716

IS - 3

ER -